Future of Closed Loop

Ed's innovative approach with bihormonal systems, incorporating stable glucagon in closed-loop pumps, shows promising results for improved outcomes in diabetes management. The evolving technology aims to enhance usability and reduce costs, potentially revolutionizing treatment options.